DOW JONES NEWSWIRES -- Pfizer Inc. (PFE) has recalled at least 12 batches of anti-impotence shot Caverject due to the potential for defective needles. The U.K. Medicines and Healthcare products Regulatory Agency issued an alert last week that Pfizer had recalled certain batches of the product because a small number of needles had blockages. This could lead to the needle bending or breaking during use, which could cause adverse events.
